Rheumatoid Arthritis Flashcards
NSAIDs
- Effect
Anti-inflammatory Action
- Decrease Prostaglandin E2
- Prostacyclin reduces vasodilation
- Reduction of mediators, number of inflammatory cells are not reduced
Analgesic Effect
- Decrease Prostaglandin generation
–> Less inflammatory mediators to activate nociceptive nerve ending
- Decreased Prostaglandin mediated vasodilation
–> Headache relief
Antipyretic Effect
- Prevent interleukin-1 from releasing prostaglandins in the CNS
–> Prevent elevation of hypothalamic set point for temperature control
–> Prevent fever
NSAIDs
- MOA
Inhibit Cyclooxygenase Enzyme (COX-1/COX2)
- Inhibiting conversion of arachidonic acid to prostaglandin
NSAIDs
- COX-1 vs COX-2
COX-1: Constitutive Enzyme
- Protective role
–> Responsible for producing cytoprotective mucus in stomach
–> Responsible for platelet aggregation
COX-1: Inducible Enzyme
- Have to be stimulated by inflammatory mediators
–> Associated with inflammation
(COX-2 has no effect on stomach)
NSAIDs
- Indication
- Pain
- Inflammation
-Fever
NSAIDs
- Adverse Effects
Contraindicated with Active Peptic Ulcer
Aspirin must be taken with food
NSAIDs
- Nonselective Adverse Effects
Gastrointestinal Effects
- Inhibition of COX-1 affects production of cytoprotective mucus)
Edema
- PG inhibits Water and Salt retention
Acute Renal Failure
- Renal PGs protect high-risk patients by countering the effect of angiotensin 2 and vasopressin
NSAIDs
- COX-2 Adverse Effects
Cardiovascular
- Caused by the disruption in the balance between platelet-activating effects of COX-1 and platelet inhibiting effects of COX-2
NSAIDs
- All Adverse Effects
CNS (Confusion, Dizziness, Depression, Hallucination)
- Likely caused by COX-2 which is abundant in the CNS
- Could also be caused by COX-3
Methotrexate
- Indication
Rheumatoid Arthritis
- Anti-inflammatory Action in small doses
Cancer
- Cytotoxic in large doses
Psoriasis Arthritis
Ankylosing Spndylitis
Polymyositis and Vaculitis
Methotrexate
- MOA
Disease-Modifying Antirheumatoid Drug (DMARD)
Folate Antagonist (Oral)
- Interferes with thymidylate synthesis (Essential in DNA synthesis)
–> Suppresses immune system
Methotrexate
- Adverse Effects
Gastrointestinal Disturbance
Dose-related Liver Toxicity
Bone Marrow Depression
Sulfasalazine
- Indication
- Rheumatoid Arthritis
- Juvenile Arthritis
- Inflammatory Bowel Disease
Sulfasalazine
- MOA
Disease-Modifying Antirheumatoid Drug (DMARD)
- Acts in the colon to release salicylic acid
–> Anti-inflammatory action
Leflunomide
- Indication
Rheumatoid Arthritis
Leflunomide
- MOA
Disease-Modifying Antirheumatoid Drug (DMARD) - (Oral)
- Increases amount of metabolite that inhibits dihydroorotate dehydrogenase
–> Inhibition of T-Cell Proliferation
–> Decreased production of autoantibodies by B cells